New Study Shows Pfizer Vaccine has Significant Effectiveness Over Omicron Variant

As shown by initial information from a South African trial that is currently undergoing critical analysis, the Omicron version significantly lowered immunogenicity created by the Pfizer-BioNTech COVID-19 vaccination.